| CLBCX | JDBAX | CLBCX / JDBAX | |
| Total Expense Ratio | 1.35 | 0.88 | 153% |
| Annual Report Gross Expense Ratio | 1.35 | 0.88 | 153% |
| Fund Existence | 24 years | 17 years | - |
| Gain YTD | 2.375 | -0.437 | -544% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 270B | 28.3B | 954% |
| Annual Yield % from dividends | 1.19 | 1.55 | 77% |
| Returns for 1 year | 10.51 | 5.06 | 208% |
| Returns for 3 years | 33.67 | 28.19 | 119% |
| Returns for 5 years | 32.27 | 24.64 | 131% |
| Returns for 10 years | 86.26 | 105.38 | 82% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CNBS | 25.36 | 0.49 | +1.97% |
| Amplify Seymour Cannabis ETF | |||
| MDYV | 89.08 | 0.31 | +0.35% |
| State Street® SPDR® S&P 400™ Md CpValETF | |||
| ZTAX | 26.11 | N/A | N/A |
| X-Square Municipal Income Tax Free ETF | |||
| UXOC | 35.91 | -0.32 | -0.90% |
| FT Vest U.S. Eq Uncppd Acceler ETF - Oct | |||
| BBH | 195.00 | -2.12 | -1.08% |
| VanEck Biotech ETF | |||